• 1. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788
• 2. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig
• 3. Evidence of field induced slow magnetic relaxation in cis-[Co(hfac)2(H2O)2] exhibiting tri-axial anisotropy with a negative axial component?
  Denis V. Korchagin,Elena A. Yureva,Alexander V. Akimov,Eugenii Ya. Misochko,Gennady V. Shilov,Artem D. Talantsev,Roman B. Morgunov,Alexander A. Shakin,Sergey M. Aldoshin,Boris S. Tsukerblat Dalton Trans., 2017,46, 7540-7548
• 4. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
• 5. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Ketones
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Carbonyl compounds Ketones

Comprehensive Guide to 1-(6-bromo-2,3-difluorophenyl)ethan-1-one (CAS No. 1542563-93-8): Properties, Applications, and Market Insights

1-(6-bromo-2,3-difluorophenyl)ethan-1-one (CAS No. 1542563-93-8) is a specialized organic compound widely used in pharmaceutical and agrochemical research. This bromo-difluorophenyl ketone derivative has gained attention due to its unique structural properties and versatility in synthetic chemistry. Researchers and manufacturers often search for high-purity 1-(6-bromo-2,3-difluorophenyl)ethan-1-one to develop novel drug candidates and advanced materials.

The molecular structure of 1-(6-bromo-2,3-difluorophenyl)ethan-1-one features a phenyl ring substituted with bromine and fluorine atoms, along with an acetyl group. This configuration makes it valuable for cross-coupling reactions in medicinal chemistry. Current trends show growing interest in fluorinated pharmaceutical intermediates, as they often enhance drug bioavailability and metabolic stability.

In pharmaceutical applications, 1-(6-bromo-2,3-difluorophenyl)ethan-1-one serves as a key building block for small molecule drug discovery. The presence of both bromine and fluorine substituents allows for selective functionalization, making it particularly useful in developing kinase inhibitors and central nervous system (CNS) drugs. Recent studies highlight its potential in creating next-generation anticancer compounds and neuroprotective agents.

The agrochemical industry utilizes 1-(6-bromo-2,3-difluorophenyl)ethan-1-one in developing advanced crop protection agents. Its structural features contribute to the creation of herbicides and pesticides with improved environmental profiles. With increasing global demand for sustainable agriculture solutions, this compound has become more relevant in green chemistry applications.

From a synthetic chemistry perspective, 1-(6-bromo-2,3-difluorophenyl)ethan-1-one demonstrates excellent reactivity in palladium-catalyzed couplings, nucleophilic aromatic substitutions, and Grignard reactions. These properties make it valuable for constructing complex molecular architectures. Researchers frequently inquire about optimized synthesis protocols for 1542563-93-8 to improve yield and purity.

The global market for halogenated aromatic ketones like 1-(6-bromo-2,3-difluorophenyl)ethan-1-one is expanding, driven by pharmaceutical R&D investments. Quality specifications typically require ≥98% purity, with strict control of heavy metal impurities and residual solvents. Suppliers offering GMP-grade 1542563-93-8 are particularly sought after by drug developers.

Storage and handling of 1-(6-bromo-2,3-difluorophenyl)ethan-1-one require standard organic compound precautions. The material should be kept in airtight containers under inert atmosphere, protected from light and moisture. These storage conditions maintain the compound's stability for extended periods, which is crucial for long-term research projects.

Analytical characterization of 1-(6-bromo-2,3-difluorophenyl)ethan-1-one typically involves HPLC analysis, mass spectrometry, and NMR spectroscopy. These techniques verify structural identity and purity, addressing common researcher concerns about batch-to-batch consistency in synthetic intermediates.

Future research directions for 1-(6-bromo-2,3-difluorophenyl)ethan-1-one include exploring its potential in material science applications, particularly in developing organic electronic materials. The compound's electron-withdrawing characteristics make it interesting for organic semiconductor research, aligning with growing interest in flexible electronics.

Environmental considerations for 1-(6-bromo-2,3-difluorophenyl)ethan-1-one focus on developing greener synthetic routes and waste minimization strategies. The pharmaceutical industry's shift toward sustainable chemistry has increased demand for eco-friendly production methods of key intermediates like this compound.

For researchers sourcing 1-(6-bromo-2,3-difluorophenyl)ethan-1-one, important considerations include supplier reliability, technical documentation quality, and regulatory compliance. The compound's patent landscape should also be reviewed when developing new applications, particularly in drug discovery programs.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)